Geode Capital Management
ETON icon

Geode Capital Management’s Eton Pharmaceutcials ETON Stock Holding History

Geode Capital Management’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.3M Buy
577,666
+12,615
+2% +$221K ﹤0.01% 2183
2025
Q4 		$9.56M Sell
565,051
-8,979
-2% -$158K ﹤0.01% 2433
2025
Q3 		$12.5M Sell
574,030
-18,835
-3% -$313K ﹤0.01% 2284
2025
Q2 		$8.45M Buy
592,865
+294,617
+99% +$4.66M ﹤0.01% 2463
2025
Q1 		$3.87M Buy
298,248
+29,602
+11% +$447K ﹤0.01% 2771
2024
Q4 		$3.58M Sell
268,646
-4,050
-1% -$41.1K ﹤0.01% 2907
2024
Q3 		$1.64M Buy
272,696
+32,365
+13% +$137K ﹤0.01% 3191
2024
Q2 		$791K Buy
240,331
+6,164
+3% +$21.6K ﹤0.01% 3397
2024
Q1 		$878K Buy
234,167
+6,911
+3% +$30.2K ﹤0.01% 3411
2023
Q4 		$996K Buy
227,256
+9,627
+4% +$38.6K ﹤0.01% 3361
2023
Q3 		$908K Buy
217,629
+7,537
+4% +$29.1K ﹤0.01% 3365
2023
Q2 		$733K Buy
210,092
+23,510
+13% +$86.5K ﹤0.01% 3475
2023
Q1 		$718K Hold
186,582
– – ﹤0.01% 3506
2022
Q4 		$522K Sell
186,582
-389
-0.2% -$1.05K ﹤0.01% 3643
2022
Q3 		$392K Hold
186,971
– – ﹤0.01% 3856
2022
Q2 		$489K Hold
186,971
– – ﹤0.01% 3778
2022
Q1 		$815K Buy
186,971
+11,118
+6% +$43.7K ﹤0.01% 3709
2021
Q4 		$754K Buy
175,853
+18,737
+12% +$89.6K ﹤0.01% 3846
2021
Q3 		$791K Buy
157,116
+1,835
+1% +$9.54K ﹤0.01% 3810
2021
Q2 		$956K Sell
155,281
-110,264
-42% -$817K ﹤0.01% 3628
2021
Q1 		$1.94M Buy
265,545
+49,506
+23% +$422K ﹤0.01% 3262
2020
Q4 		$1.76M Buy
216,039
+68,212
+46% +$526K ﹤0.01% 3152
2020
Q3 		$1.17M Buy
147,827
+41,815
+39% +$285K ﹤0.01% 3150
2020
Q2 		$577K Buy
+106,012
New +$526K ﹤0.01% 3319

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return

Geode Capital Management's ETON Position: Q1 2026 in Review

Geode Capital Management increased its Eton Pharmaceutcials (ETON) stake by 2.2% in Q1 2026, buying an estimated $221K and bringing the position to 577,666 shares worth $14.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2183.

Geode Capital Management first reported a position in ETON in Q2 2020 and has held it in 24 quarters since. 116 funds tracked by Wall St. Rank hold ETON as of Q1 2026.

  • Geode Capital Management held 577,666 shares of Eton Pharmaceutcials worth $14.3M as of Q1 2026.
  • Geode Capital Management bought 12,615 Eton Pharmaceutcials shares in Q1 2026, an estimated $221K.
  • Eton Pharmaceutcials made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #2183 holding.
  • Geode Capital Management first reported a position in Eton Pharmaceutcials in Q2 2020 and has held it in 24 quarters since.
  • 116 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.